Immunohematology - Medical Devices Pipeline Assessment, 2019

Immunohematology - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Immunohematology - Medical Devices Pipeline Assessment, 2019 provides an overview of Immunohematology currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Immunohematology pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Immunohematology under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunohematology and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunohematology under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Immunohematology Overview
  • Products under Development
    • Immunohematology - Pipeline Products by Stage of Development
      • Table Figure 1: Immunohematology - Pipeline Products by Stage of Development
      • Table Immunohematology - Pipeline Products by Stage of Development
    • Immunohematology - Pipeline Products by Segment
      • Table Figure 2: Immunohematology - Pipeline Products by Segment
      • Table Immunohematology - Pipeline Products by Segment
    • Immunohematology - Pipeline Products by Territory
      • Table Figure 3: Immunohematology - Pipeline Products by Territory
      • Table Immunohematology - Pipeline Products by Territory
    • Immunohematology - Pipeline Products by Regulatory Path
      • Table Figure 4: Immunohematology - Pipeline Products by Regulatory Path
      • Table Immunohematology - Pipeline Products by Regulatory Path
    • Immunohematology - Pipeline Products by Estimated Approval Date
      • Table Figure 5: Immunohematology - Pipeline Products by Estimated Approval Date
      • Table Immunohematology - Pipeline Products by Estimated Approval Date
  • Immunohematology - Pipeline Products under Development by Companies
    • Immunohematology Companies - Pipeline Products by Stage of Development
      • Table Immunohematology Companies - Pipeline Products by Stage of Development
    • Immunohematology - Pipeline Products by Stage of Development
      • Table Immunohematology - Pipeline Products by Stage of Development
  • Immunohematology Companies and Product Overview
    • AbSorber AB Company Overview
      • AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
        • Table ABO Diagnostic Test - Product Status
        • Table ABO Diagnostic Test - Product Description
    • Alba Bioscience Limited Company Overview
      • Alba Bioscience Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table Alba Bioscience Limited Pipeline Products & Ongoing Clinical Trials Overview
        • Table ALBAcyte O Adult i Cell Reagent - Product Status
        • Table ALBAcyte O Adult i Cell Reagent - Product Description
        • Table ALBAcyte O RhD VI Reagent Cells - Product Status
        • Table ALBAcyte O RhD VI Reagent Cells - Product Description
    • Amity University Company Overview
      • Amity University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Amity University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood Group Testing Kit - Product Status
        • Table Blood Group Testing Kit - Product Description
    • Arizona State University Company Overview
      • Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Arizona State University Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood Screening Immunosignaturing - Product Status
        • Table Blood Screening Immunosignaturing - Product Description
    • Biofortuna Ltd Company Overview
      • Biofortuna Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biofortuna Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table HemoPlex Kell Genotyping Kit - Product Status
        • Table HemoPlex Kell Genotyping Kit - Product Description
        • Table HemoPlex Kidd & Duffy Genotyping Kit - Product Status
        • Table HemoPlex Kidd & Duffy Genotyping Kit - Product Description
        • Table HemoPlex MNS Genotyping Kit - Product Status
        • Table HemoPlex MNS Genotyping Kit - Product Description
        • Table HemoPlex Multi Blood Group Genotyping Kit - Product Status
        • Table HemoPlex Multi Blood Group Genotyping Kit - Product Description
        • Table HemoPlex RHCE Screening Kit - Product Status
        • Table HemoPlex RHCE Screening Kit - Product Description
        • Table HemoPlex RHCE Variant Genotyping Kit - Product Status
        • Table HemoPlex RHCE Variant Genotyping Kit - Product Description
        • Table HemoPlex RHD & CE Genotyping Kit - Product Status
        • Table HemoPlex RHD & CE Genotyping Kit - Product Description
        • Table HemoPlex RHD Variant Genotyping Kit - Product Status
        • Table HemoPlex RHD Variant Genotyping Kit - Product Description
        • Table ThromboPlex HPA Screening Kit - Product Status
        • Table ThromboPlex HPA Screening Kit - Product Description
    • Grifols SA Company Overview
      • Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table IH Blood Genotyping (D) Kit - Product Status
        • Table IH Blood Genotyping (D) Kit - Product Description
    • Ortho-Clinical Diagnostics Inc Company Overview
      • Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ORTHO AutoVue - Rare Sera Assay - Product Status
        • Table ORTHO AutoVue - Rare Sera Assay - Product Description
        • Table ORTHO BioVue - Rare Sera Assay - Product Status
        • Table ORTHO BioVue - Rare Sera Assay - Product Description
    • Quotient Ltd Company Overview
      • Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Eluate Kit - Product Status
        • Table Eluate Kit - Product Description
        • Table Expanded IH Microarray - Product Status
        • Table Expanded IH Microarray - Product Description
        • Table IH Microarray Patient - Product Status
        • Table IH Microarray Patient - Product Description
        • Table Polyagglutionation Kit - Product Status
        • Table Polyagglutionation Kit - Product Description
        • Table Sensitivity Kit Anti-S, K, e, C - Product Status
        • Table Sensitivity Kit Anti-S, K, e, C - Product Description
    • Transfusion & Transplantation Technologies (Inactive) Company Overview
      • Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table Aegis - Anti-A Quantitation In Group O Platelets - Product Status
        • Table Aegis - Anti-A Quantitation In Group O Platelets - Product Description
        • Table Aegis - Antibody Screening And Identification Assay - Product Status
        • Table Aegis - Antibody Screening And Identification Assay - Product Description
        • Table Aegis - Blood Grouping Assay - Product Status
        • Table Aegis - Blood Grouping Assay - Product Description
        • Table Aegis - Platelet Cross-match Assay - Product Status
        • Table Aegis - Platelet Cross-match Assay - Product Description
        • Table Aegis - Residual A Quantitation Assay - Product Status
        • Table Aegis - Residual A Quantitation Assay - Product Description
        • Table Aegis - rWBC Quantitation Assay - Product Status
        • Table Aegis - rWBC Quantitation Assay - Product Description
        • Table AEGIS System - Product Status
        • Table AEGIS System - Product Description
  • Immunohematology- Recent Developments
    • Nov 04, 2019: Quotient reports second quarter fiscal 2020 financial results
    • Nov 01, 2019: Haemonetics reports 2nd quarter and 1st half fiscal 2020 results; raises fiscal 2020 adjusted operating margin and adjusted EPS guidance
    • Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results
    • Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results.
    • Oct 14, 2019: Biocare Medical appoints Nicolas Barthelemy as Executive Chairman
    • Sep 24, 2019: Theradiag announces improved results for H1 2019
    • Sep 12, 2019: Haemonetics Appoints Stewart W. Strong As President, Global Hospital
    • Sep 11, 2019: Bio-Rad files new lawsuit against 10X Genomics for Patent Infringement
    • Aug 29, 2019: Siemens Healthineers announces new Canadian leadership
    • Aug 06, 2019: Haemonetics reports 1st Quarter Fiscal 2020 results, updates Fiscal 2020 earnings guidance and launches operational excellence program
    • Aug 05, 2019: Quotient Limited Provides Updates on European Hypercare Launch, the CE Mark Submission and U.S. Field Trial for the Initial Serological Disease Screening Microarray, and Reports First Quarter Fiscal 2020 Results
    • Aug 01, 2019: Bio-Rad reports second-quarter 2019 financial results
    • Jul 31, 2019: Grifols increases its revenues by 14.3% to EUR 2,423 million, driven by its strategic growth plan
    • Jul 29, 2019: Siemens Healthineers continues to drive growth forward
    • Jul 29, 2019: Changes in the Managing Board of Siemens Healthineers
    • Jul 24, 2019: Delaware District Court grants Bio-Rad's Motion for Permanent Injunction against 10X Genomics
    • Jul 18, 2019: Theradiag announces first-half revenue up 9%
    • Jul 02, 2019: Quotient Board announces contract extension of CEO Franz Walt
    • Jun 26, 2019: LABScreen Single Antigen ExPlex - Introducing the Most Expansive HLA Antibody Test in a Single Well
    • May 29, 2019: Quotient recaps recent milestone achievement and updates on the initial serological disease screening CE Mark Submission, planned 2019 US field trials and reports record financial results
    • May 24, 2019: Grifols reinforces its long-term and sustainable growth strategy with EUR 1,400 million in capital investments in 2018-2022
    • May 14, 2019: Ortho Clinical Diagnostics to host 4th Annual Hospital C-Suite Summit in Singapore
    • May 08, 2019: Grifols reports 13% revenue growth to EUR 1,157 million and confirms its solid operational performance
    • May 08, 2019: Bio-Rad reports first quarter 2019 financial results
    • May 07, 2019: Haemonetics reports 4th quarter and fiscal year 2019 results and provides fiscal year 2020 guidance; board of directors authorizes new $500 million share repurchase program
    • May 02, 2019: Siemens Healthineers posts strong revenue and profit growth in the second quarter
    • May 01, 2019: Quotient receives European CE Mark for its Initial IH Microarray
    • Apr 30, 2019: Immucor announces Health Canada approval for NEO Iris; next generation, fully automated instrument for transfusion medicine
    • Apr 29, 2019: Grifols announces the opening of its new Plasma Donor Center in Hinesville, Georgia
    • Apr 29, 2019: Claire Pomeroy joins Haemonetics Board of Directors
    • Apr 22, 2019: Bio-Rad Laboratories names Andrew Last as executive vice president and chief operating officer
    • Apr 04, 2019: Theradiag and HOB Biotech settle their legal dispute
    • Apr 02, 2019: Bio-Rad Laboratories appoints Ilan Daskal as executive vice president and chief financial officer
    • Mar 27, 2019: Theradiag reports its 2018 full-year results
    • Feb 28, 2019: Grifols reports EUR 4,487 million in revenues, with 9.2% operating growth and EUR 597 million in net profit
    • Feb 28, 2019: Bio-Rad Laboratories announces fourth-quarter and full-year 2018 financial results
    • Feb 20, 2019: Theradiag reports annual revenues for 2018 and its year-end cash position
    • Feb 11, 2019: Siemens Healthineers to invest EUR 350 million in new Campus Forchheim
    • Feb 05, 2019: Haemonetics reports 3rd quarter and year-to-date fiscal 2019 results; raises cash flow guidance and reaffirms other fiscal 2019 guidance
    • Jan 28, 2019: Ortho Clinical Diagnostics names Robert Yates as Next Chairman and CEO
    • Jan 15, 2019: THERADIAG reaffirms its leadership position in biotherapy monitoring with a new test being granted the CE mark
    • Jan 03, 2019: Bio-Rad finance chief to retire
    • Jan 03, 2019: Christine Tsingos announces plans to retire as CFO of Bio-Rad Laboratories
    • Dec 19, 2018: Haemonetics announces headquarters relocation to Boston
    • Dec 11, 2018: TheraDiag names Bertrand de Castelnau as Chief Executive Officer
    • Dec 04, 2018: 10 Billion Lab Tests and Growing: Siemens Healthineers Mass. Manufacturing Expansion Largely Completed
    • Dec 04, 2018: 10 billion lab tests and growing: Siemens Healthineers mass. manufacturing expansion largely completed
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook